Psychedelic Research Recap November 2025
Psychedelic research in November examined microdosing outcomes, brain criticality and plasticity mechanisms, and clinical applications for depression, PTSD, and end-of-life care.
Floris Wolswijk
Psychedelic Research Recap October 2025
Psychedelic research in October investigated brain plasticity, set and setting, and microdosing.
Psychedelic Research Recap September 2025
Psychedelic research in September focussed on MDMA, psilocybin, LSD, and ayahuasca clinical trials across diverse indications.
What Does the Psychedelic Literature Say About Kindness Towards Oneself?
Can psychedelics teach us kindness to oneself? Exploring research on how these experiences shape self-kindness, acceptance & inner healing
Psychedelic Research Recap August 2025
Psychedelic research in August 2025 (162 studies, 10 added to the database) looked at psilocybin for PTSD, economic evaluations of psychedelic therapies, the brain mechanisms of tabernanthalog, and much more.
Psychedelic Research Recap July 2025
Psychedelic research in July 2025 (181 studies, 18 added to the database) looked at the receptors psychedelics influence, naturalistic psychedelic use, and much more.
Psychedelic Research Recap June 2025
Psychedelic research in June 2025 (146 studies, 18 added to the database) looked at long-term effects of psilocybin therapy for depression, ‘meaning of life’ after psychedelic use, unblinding effects, and more.
Psychedelic Research Recap May 2025
Psychedelic research in May 2025 shows ketamine saves healthcare costs, esketamine remains safe long-term, and these therapies work differently than expected.
Psychedelic Research Recap April 2025
In April 2025, psychedelic researchers published 172 studies and we’ve added 17 new papers to the database. This month featured ketamine for smoking cessation, HPPD after psychedelic use, effects of DMT on TRD, and much more.
Psychedelic Landscape – Request for Feedback
For the past six years, Blossom has tracked all psychedelic research and distilled the findings for researchers, clinicians and the curious. Along the way, we noticed a glaring gap: knowing what the science says is only half the story—understanding who can turn that science into real-world impact is the other half. Today, we are closing …